Fate Therapeutics Cash Flow Statement (2012-2025) | FATE

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Operating Activities
Net Income (Quarter)	-45.83M	-46.43M	-54.33M	-69.08M	-74.05M	-82.35M	-84.60M	-61.54M	-24.90M	-58.18M	-46.58M	-43.66M	-46.92M	-40.26M	-47.94M	-57.87M	-37.94M	-34.05M	-32.16M	-32.50M
Share-based Compensation (Quarter)	12.98M	13.25M	13.54M	14.59M	19.33M	20.54M	19.47M	19.39M	10.98M	12.90M	10.10M	9.47M	10.98M	9.63M	11.77M	9.12M	7.38M	7.15M	4.86M	5.53M
Gains from Sales and Divestitures (Quarter)
Gains from Investment Securities (Quarter)	1.44M	0.10M		7.05M			0.16M					-0.06M			-0.94M					-0.04M
Non-cash Items (Quarter)
Cash from Operations (Quarter)	-27.10M	-32.11M	-33.38M	-70.29M	-64.61M	-53.16M	-55.05M	-75.39M	-28.86M	-28.49M	-38.27M	-36.64M	-33.35M	-32.31M	-29.42M	-27.80M	-33.81M	-24.59M	-24.37M	-23.31M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	-1.14M	-1.49M	-1.37M	-1.07M	-0.87M	-0.53M	0.41M	1.25M	2.29M	2.94M	3.26M	2.91M	2.63M	2.72M	2.20M	1.53M	1.07M	0.85M	0.81M	0.88M
Amortization of Deferred Charges (Quarter)	0.62M	0.98M	1.11M	1.29M	1.09M	-0.33M	0.78M	1.13M	7.20M
Depreciation & Amortization (CF) (Quarter)	0.96M	1.17M	1.52M	2.26M	2.76M	2.96M	3.19M	4.84M	4.19M	4.47M	4.74M	4.90M	4.82M	4.72M	4.61M	4.81M	3.33M	3.28M	3.23M	3.06M
Change in Working Capital
Change in Receivables (Quarter)	1.43M	3.36M	-2.99M	1.36M	5.17M	-0.72M	-2.90M	28.26M	-24.98M	-10.67M	-1.30M	0.29M	-0.97M	0.19M	2.48M	-0.59M	-1.13M	-1.01M	-0.71M	0.23M
Change in Accured Expenses (Quarter)	6.94M	2.61M	6.74M	-10.38M	-3.49M	4.08M	10.28M	3.39M	-20.39M	-4.37M	-2.28M	-1.89M	-4.51M	0.32M	1.87M	0.66M	-9.83M	0.48M	-0.55M	0.86M
Investing Activities
Capital Expenditures (Quarter)	2.62M	-1.19M	30.90M	-27.96M	10.08M	-8.62M	0.52M	33.58M	3.21M	2.20M	0.56M	-5.97M	0.01M	0.12M	-0.12M	0.71M	0.66M	1.90M	-2.16M	5.55M
Sales of Property, Plant and Equipment (Quarter)																			0.00M	0.24M
Change in Acquisitions & Divestments (Quarter)	62.00M	111.58M	258.16M	263.09M	135.22M	114.36M	190.63M	166.89M	127.00M	127.63M	127.50M	95.50M	103.73M	75.34M	90.70M	60.92M	92.49M	71.64M	81.45M	66.32M
Cash from Investing Activities (Quarter)	-471.89M	-1.37M	77.96M	71.28M	-7.03M	40.29M	80.38M	53.11M	9.34M	33.17M	24.80M	45.35M	17.31M	-53.37M	25.46M	22.82M	42.67M	19.59M	21.27M	27.63M
Financing Activities
Other financing activities (Quarter)										0.06M			0.56M	-0.56M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
Long-Term Debt Repayments (Quarter)
Change in Capital Stock
Shares Issued (Quarter)	5.61M	3.72M	11.36M	-20.68M	2.80M	3.41M	1.49M	1.52M		0.27M		-0.27M	20.00M	54.53M	-54.53M	-19.70M
Shares Repurchased (Quarter)
Preferred Shares Issued (Quarter)
Misc.
Cash from Financing Activities (Quarter)	438.05M	3.72M	7.94M	3.42M	2.80M	3.41M	1.49M	1.52M	0.21M	0.06M		-0.18M	95.49M	1.27M		3.13M		1.32M	2.48M	1.69M
Change in Cash (Quarter)	-60.93M	-29.76M	52.53M	4.40M	-68.84M	-9.47M	26.82M	-20.76M	-19.31M	4.73M	-13.47M	8.54M	79.45M	-84.41M	-3.96M	-1.85M	8.86M	-3.67M	-0.63M	6.01M
Free Cash Flow (Quarter)	-29.72M	-30.92M	-64.28M	-42.33M	-74.70M	-44.54M	-55.57M	-108.97M	-32.07M	-30.69M	-38.84M	-30.66M	-33.36M	-32.43M	-29.30M	-28.51M	-34.46M	-26.49M	-22.21M	-28.87M
Net Cash Flow (Quarter)	-60.93M	-29.76M	52.53M	4.40M	-68.84M	-9.47M	26.82M	-20.76M	-19.31M	4.73M	-13.47M	8.54M	79.45M	-84.41M	-3.96M	-1.85M	8.86M	-3.67M	-0.63M	6.01M

Research Tools

Fate Therapeutics Cash Flow Statement (2012-2025) | FATE

Create an account

Sign In

Reset Password